Evidence map›Paper›PMID 31537797›Full record

ArticleNature communications2019

MRE11-RAD50-NBS1 promotes Fanconi Anemia R-loop suppression at transcription-replication conflicts.

Emily Yun-Chia Chang, Shuhe Tsai, Maria J Aristizabal, James P Wells, Yan Coulombe, Franciele F Busatto, Yujia A Chan, Arun Kumar, Yi Dan Zhu, Alan Ying-Hsu Wang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Transcription-Replication Conflicts: Unlocking New Frontiers in Cancer.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Mechanisms underlining R-loop biology and implications for human disease.Frontiers in cell and developmental biology · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Emily Yun-Chia ChangTerry Fox Laboratory, BC Cancer, Vancouver, V5Z 1L3, Canada.
Shuhe TsaiTerry Fox Laboratory, BC Cancer, Vancouver, V5Z 1L3, Canada.
Maria J AristizabalCentre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, Vancouver, V5Z 4H4, Canada.
James P WellsTerry Fox Laboratory, BC Cancer, Vancouver, V5Z 1L3, Canada.
Yan CoulombeCentre Hospitalier Universitaire de Québec-Universite Laval, Oncology Axis, Quebec City, G1R 2J6, Canada.
Franciele F BusattoCentre Hospitalier Universitaire de Québec-Universite Laval, Oncology Axis, Quebec City, G1R 2J6, Canada.
Yujia A ChanThe Broad Institute of MIT and Harvard University, Cambridge, MA, 02142, USA.
Arun KumarTerry Fox Laboratory, BC Cancer, Vancouver, V5Z 1L3, Canada.
Yi Dan ZhuTerry Fox Laboratory, BC Cancer, Vancouver, V5Z 1L3, Canada.
Alan Ying-Hsu WangTerry Fox Laboratory, BC Cancer, Vancouver, V5Z 1L3, Canada.
Louis-Alexandre FournierTerry Fox Laboratory, BC Cancer, Vancouver, V5Z 1L3, Canada.
Philip HieterMichael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada.
Michael S KoborCentre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, Vancouver, V5Z 4H4, Canada.ORCID http://orcid.org/0000-0003-4140-1743
Jean-Yves MassonCentre Hospitalier Universitaire de Québec-Universite Laval, Oncology Axis, Quebec City, G1R 2J6, Canada.
Peter C StirlingTerry Fox Laboratory, BC Cancer, Vancouver, V5Z 1L3, Canada. pstirling@bccrc.ca.
Terry Fox Research Institute · CACentre hospitalier universitaire de Québec · CABC Children's Hospital · CAUniversity of British Columbia · CABroad Institute · US

Funding

CIHR MOP136-982
6 · The paper itself

Abstract

Ectopic R-loop accumulation causes DNA replication stress and genome instability. To avoid these outcomes, cells possess a range of anti-R-loop mechanisms, including RNaseH that degrades the RNA moiety in R-loops. To comprehensively identify anti-R-loop mechanisms, we performed a genome-wide trigenic interaction screen in yeast lacking RNH1 and RNH201. We identified >100 genes critical for fitness in the absence of RNaseH, which were enriched for DNA replication fork maintenance factors including the MRE11-RAD50-NBS1 (MRN) complex. While MRN has been shown to promote R-loops at DNA double-strand breaks, we show that it suppresses R-loops and associated DNA damage at transcription-replication conflicts. This occurs through a non-nucleolytic function of MRE11 that is important for R-loop suppression by the Fanconi Anemia pathway. This work establishes a novel role for MRE11-RAD50-NBS1 in directing tolerance mechanisms at transcription-replication conflicts.

Indexed as

Acid Anhydride HydrolasesCell Cycle ProteinsDNA-Binding ProteinsDNA DamageDNA ReplicationFanconi AnemiaGenomic InstabilityHumansMRE11 Homologue ProteinNuclear ProteinsRibonuclease HR-Loop StructuresSchizosaccharomycesTranscription, GeneticAcid Anhydride HydrolasesCell Cycle ProteinsDNA-Binding ProteinsMRE11 Homologue ProteinMRE11 protein, humanNBN protein, humanNuclear ProteinsRAD50 protein, humanRibonuclease H

Identifiers

PMID31537797
PMCPMC6753070
OpenAlexW2974301258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.